David M. Fox | Washington, D.C. | Hogan Lovells

David M. Fox
Fox David
  • Overview
  • Experience
  • Credentials
  • Insights and events
quote mark

"We love the tremendous expertise that David Fox brings to our strategic product development initiatives."

Chambers 2013

David Fox is a leading authority on the regulation of prescription and over-the-counter drugs, biological products, combination products, and controlled substances. 

He advises management teams, from start-ups to the largest global pharmaceutical and biotechnology companies, on matters before the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA). David is closely integrated with funding sources for the industry and is frequently retained as a strategic advisor on assessing the value of life sciences assets. Known for his collaborative approach to complex regulatory issues, David has successfully resolved numerous disputes between sponsors and staff at FDA on products that raise novel regulatory issues. As a former senior lawyer for FDA and throughout his career in private practice, David has been deeply immersed in the regulatory side of the Hatch-Waxman Act, including pioneer-generic disputes and numerous cases of first impression involving exclusivity issues, Orange Book listings, and patent term extensions. 

David previously led our Pharmaceutical and Biotechnology practice group and served on the firm's global Life Sciences management team.

During his FDA tenure, David received the Secretary’s Award of Merit and an FDA Special Citation for his work on the FDA Tobacco Rule. David is a founding member of the Kitalys Institute to support interventions that delay the onset of diseases of aging, and David is on the Advisory Board of the Cancer Support Community. David also serves as pro bono counsel on a variety of programs to improve patient and care-giver welfare.

quote mark

"David Fox is recognized for the quality of his strategic counsel on engagements with the FDA for 505 (b)(2) New Drug Applications. 'I would never do a pharmaceuticals deal without his involvement. His insights into FDA regulatory matters is unparalleled,' says one impressed source."

Chambers USA 2016


  • J.D., New York University School of Law, 1989
  • B.A., College of William & Mary, 1985
Bar admissions and qualifications
  • District of Columbia
  • New York


Life Sciences: Regulatory/Compliance (Nationwide), Band 1

Chambers USA

Healthcare: Pharmaceutical/Medical Products Regulatory (District of Columbia), Band1

Chambers USA

Life Sciences: Regulatory/Compliance (USA)

Chambers Global

Life Sciences Hall of Fame

LMG Life Sciences


Best Lawyers in America

Healthcare: Life Sciences, Hall of Fame

Legal 500 US

Healthcare: Life Sciences, Leading Lawyer

Legal 500 US

2013-2014, 2016-2018
Thought Leaders, USA, Life Sciences - Regulatory

Who's Who Legal

Selected to Super Lawyers

Washington's Top Lawyers: Food and Drug


2009, 2011, 2013, 2014
Most Highly Regarded Firms for Life Sciences

Who's Who Legal


PLC Life Sciences Cross-border Handbook

USA – Life Sciences: Regulatory, Recommended

PLC Which Lawyer?

FDA Award of Merit and Special Citation

Secretary's Award for Distinguished Service